Africa Oil (OTCMKTS:AOIFF) will be posting its quarterly earnings results after the market closes on Tuesday, August 14th.
Africa Oil opened at $0.96 on Friday, according to Marketbeat. The company has a market capitalization of $420.40 million, a P/E ratio of -96.12 and a beta of 1.82. Africa Oil has a 12-month low of $0.84 and a 12-month high of $1.55.
Get Africa Oil alerts:
Separately, ValuEngine raised shares of Africa Oil from a “strong sell” rating to a “sell” rating in a report on Wednesday, May 2nd.
Africa Oil Company Profile
Africa Oil Corp., together with its subsidiaries, operates as an oil and gas exploration and development company in Kenya and Ethiopia. It holds interests primarily in the East African Rift Basin. The company was formerly known as Canmex Minerals Corporation and changed its name to Africa Oil Corp. in August 2007.
Top 10 Value Stocks To Watch Right Now: Capital Senior Living Corporation(CSU)
Advisors’ Opinion:
- [By Logan Wallace]
Barclays reissued their average rating on shares of Capital Senior Living (NYSE:CSU) in a research note released on Monday morning.
Several other equities analysts have also issued reports on the company. ValuEngine lowered Capital Senior Living from a strong-buy rating to a buy rating in a research note on Thursday, December 27th. JMP Securities restated an outperform rating on shares of Capital Senior Living in a research note on Monday, December 31st. Finally, Zacks Investment Research upgraded Capital Senior Living from a hold rating to a buy rating and set a $8.75 price target on the stock in a research note on Monday, January 21st. Four research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. Capital Senior Living presently has a consensus rating of Hold and an average price target of $9.38.
- [By Shane Hupp]
$900.00 upgraded shares of Constellation Software (TSE:CSU) from a neutral rating to an outperform rating in a report issued on Tuesday morning.
Other equities analysts have also issued reports about the stock. National Bank Financial lifted their price target on shares of Constellation Software from C$850.00 to C$875.00 and gave the stock a sector perform rating in a report on Friday, April 27th. CIBC lifted their price target on shares of Constellation Software from C$865.00 to C$900.00 in a report on Friday, April 27th. lifted their price target on shares of Constellation Software to C$980.00 in a report on Thursday, April 26th. Finally, Scotiabank lifted their price target on shares of Constellation Software from C$880.00 to C$940.00 and gave the stock an outperform rating in a report on Tuesday, April 24th. Four equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. The stock has an average rating of Hold and a consensus price target of C$901.88.
- [By Stephan Byrd]
Media stories about Capital Senior Living (NYSE:CSU) have trended somewhat positive on Sunday, Accern Sentiment Analysis reports. The research firm rates the sentiment of press coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Capital Senior Living earned a daily sentiment score of 0.01 on Accern’s scale. Accern also assigned press coverage about the company an impact score of 46.062391046142 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.
Top 10 Value Stocks To Watch Right Now: Capella Education Company(CPLA)
Advisors’ Opinion:
- [By Logan Wallace]
Get a free copy of the Zacks research report on Capella Education (CPLA)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Logan Wallace]
Shares of Capella Education (NASDAQ:CPLA) reached a new 52-week high on Monday . The stock traded as high as $104.10 and last traded at $103.20, with a volume of 487 shares trading hands. The stock had previously closed at $103.70.
Top 10 Value Stocks To Watch Right Now: Prudential Financial Inc.(PRU)
Advisors’ Opinion:
- [By ]
Along with index ETFs, consider redeploying the capital into solid dividend producing names like Prudential Financial (NYSE: PRU), AT&T (NYSE: T) and Omega Health Care (NYSE: OHI) for their expected future stability and consistent dividend payouts.
- [By Shane Hupp]
NN Investment Partners Holdings N.V. increased its holdings in Prudential Financial Inc (NYSE:PRU) by 0.1% during the 2nd quarter, Holdings Channel reports. The firm owned 2,197,076 shares of the financial services provider’s stock after buying an additional 2,780 shares during the period. Prudential Financial accounts for approximately 1.5% of NN Investment Partners Holdings N.V.’s portfolio, making the stock its 10th largest position. NN Investment Partners Holdings N.V.’s holdings in Prudential Financial were worth $205,450,000 at the end of the most recent reporting period.
- [By Stephan Byrd]
Symphony Asset Management LLC lowered its position in Prudential Financial Inc (NYSE:PRU) by 18.9% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 16,149 shares of the financial services provider’s stock after selling 3,765 shares during the period. Symphony Asset Management LLC’s holdings in Prudential Financial were worth $1,672,000 as of its most recent SEC filing.
Top 10 Value Stocks To Watch Right Now: Bayer Aktiengesellschaft (BAYRY)
Advisors’ Opinion:
- [By Todd Campbell]
Based on the company’s results, Bayer AG (NASDAQOTH:BAYRY) licensed the rights to larotrectinib in a nine-figure deal that included $400 million up front and up to $450 million in regulatory and first-sale milestones. The two companies will split profit in the United States. Outside the U.S., Loxo Oncology will get tiered double-digit royalties based on sales levels, as well as up to $475 million in sales-based milestones.
- [By ]
Major competitive vendors that are developing treatments for pericarditis include:
Pfizer Inc. (PFE) Abbvie, Inc. (ABBV) XBiotech Inc. (XBIT) Handok AstraZeneca (AZN) Bayer AG (OTCPK:BAYRY) Reckitt Benckiser Group plc. (RB) PerkinElmer, Inc. (PKI) FUJIFILM Holdings Corporation (OTCPK:FUJIY) Merck Sharp & Dohme Corp. (MRK) ALLERGAN (AGN)
Concerning competitive advantage, management of the company is not aware of any therapies currently approved by the FDA for the treatment of recurrent pericarditis, the firm’s lead indication for rilonacept.
- [By ]
Both companies reported that the phase 3 trial known as IMblaze370 had failed. This study recruited a total of 363 patients with locally advanced or metastatic colorectal cancer. One key thing to note first is that the patients that were recruited into the study, were those who had already been heavily pretreated with 2 or more prior regimens of chemotherapy. The trial was putting the combination of Tecentriq and Cotellic versus the control arm which was regorafenib (STIVARGA) from Bayer (OTCPK:BAYRY). Unfortunately, the treatment combination arm failed to improve overall survival versus the control arm. There was no actual results released yet. It was stated that full detailed results from this study will be released at an upcoming medical conference. The problem is that it doesn’t matter what the results are, the bottom-line is that the primary endpoint was not met.
- [By ]
And why did Bayer (OTCPK:BAYRY) buy this drug, too?
Unfortunately, in most cases, resistance is inevitable at some point, even if you attain a strong response that lasts a while. It is a near-truism that patients will eventually acquire resistance to kinase inhibitors, except in rare exceptional circumstances and treatment settings like chronic myeloid leukemia, where a lot of patients can have a persistent remission for years and years.
- [By ]
Bayer AG (BAYRY) also rose 4.13% to €97.29 on reports that its mega-merger with Monsanto Co. (MON) would likely be approved by the Department of Justice. The Wall Street Journal reported that the companies have agreed additional asset sales.
Top 10 Value Stocks To Watch Right Now: THL Credit, Inc.(TCRD)
Advisors’ Opinion:
- [By Max Byerly]
Thl Credit (NASDAQ: TCRD) and Tian Ge Interactiv (OTCMKTS:TGRVF) are both small-cap finance companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, dividends, analyst recommendations, profitability, risk, institutional ownership and valuation.
- [By Ethan Ryder]
Get a free copy of the Zacks research report on THL Credit (TCRD)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Ethan Ryder]
THL Credit, Inc. (NASDAQ:TCRD) CFO Terrence W. Olson purchased 11,511 shares of the firm’s stock in a transaction on Friday, May 11th. The stock was bought at an average price of $7.86 per share, for a total transaction of $90,476.46. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website.
- [By Max Byerly]
THL Credit, Inc. (NASDAQ:TCRD) CFO Terrence W. Olson acquired 10,200 shares of the business’s stock in a transaction on Wednesday, May 9th. The stock was acquired at an average price of $7.80 per share, for a total transaction of $79,560.00. The acquisition was disclosed in a document filed with the SEC, which is available at this link.
Top 10 Value Stocks To Watch Right Now: Petroleum Resources Corporation(PEO)
Advisors’ Opinion:
- [By Shane Hupp]
Press coverage about Adams Natural Resources Fund (NYSE:PEO) has trended somewhat negative recently, Accern reports. The research group identifies positive and negative news coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Adams Natural Resources Fund earned a coverage optimism score of -0.09 on Accern’s scale. Accern also assigned news articles about the financial services provider an impact score of 48.0521373671292 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.
Top 10 Value Stocks To Watch Right Now: Masimo Corporation(MASI)
Advisors’ Opinion:
- [By Logan Wallace]
Get a free copy of the Zacks research report on Masimo (MASI)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Keith Speights]
Masimo (NASDAQ:MASI) showed that it continues to fire on all cylinders when it reported its third-quarter results in November. The company posted solid revenue growth for its noninvasive monitoring technologies with exceptionally strong earnings growth.
- [By Stephan Byrd]
Masimo Co. (NASDAQ:MASI) insider Ramshorst David J. Van sold 1,325 shares of the firm’s stock in a transaction that occurred on Monday, October 1st. The stock was sold at an average price of $125.00, for a total transaction of $165,625.00. Following the completion of the sale, the insider now directly owns 2,325 shares in the company, valued at $290,625. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.
- [By Keith Noonan]
Masimo Corporation (NASDAQ:MASI) stock climbed 18.6% in August, according to data provided by S&P Global Market Intelligence. The healthcare technology and device company’s share price jumped following the publication of its second-quarter results and continued to climb throughout the month.
Top 10 Value Stocks To Watch Right Now: Sphere 3D Corp.(ANY)
Advisors’ Opinion:
- [By Max Byerly]
Sphere 3D Corp (NASDAQ:ANY) was down 0% during trading on Tuesday . The stock traded as low as $0.31 and last traded at $0.34. Approximately 6,746 shares changed hands during trading, a decline of 99% from the average daily volume of 962,980 shares. The stock had previously closed at $0.34.
- [By Paul Ausick]
Sphere 3D Corp. (NASDAQ: ANY) fell by more than 48% Friday to post a new 52-week low of $0.57 after closing at $1.10 on Thursday. The 52-week high is $7.25. Volume of about 5.3 million was more than 10 times the daily average. Another secondary stock offering. This time 3.3 million shares plus warrants at $0.70.
- [By Shane Hupp]
MINDBODY (NASDAQ: MB) and Sphere 3D (NASDAQ:ANY) are both small-cap computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, earnings, valuation and risk.
- [By Joseph Griffin]
Sphere 3D (NASDAQ:ANY) saw unusually-strong trading volume on Monday . Approximately 2,577,171 shares were traded during trading, an increase of 254% from the previous session’s volume of 727,835 shares.The stock last traded at $0.49 and had previously closed at $0.38.
- [By Ethan Ryder]
Shares of Sphere 3D Corp (NASDAQ:ANY) were down 9.4% during trading on Thursday . The stock traded as low as $0.29 and last traded at $0.29. Approximately 2,010 shares traded hands during mid-day trading, a decline of 100% from the average daily volume of 769,788 shares. The stock had previously closed at $0.32.
- [By Joseph Griffin]
Sphere 3D (NASDAQ:ANY) was upgraded by equities research analysts at ValuEngine from a “hold” rating to a “buy” rating in a note issued to investors on Monday.
Top 10 Value Stocks To Watch Right Now: Pacific Biosciences of California Inc.(PACB)
Advisors’ Opinion:
- [By Logan Wallace]
Shares of Pacific Biosciences of California (NASDAQ:PACB) gapped up prior to trading on Thursday . The stock had previously closed at $4.99, but opened at $4.87. Pacific Biosciences of California shares last traded at $5.16, with a volume of 170693 shares traded.
- [By Keith Speights]
Illumina announced in November that it plans to acquire Pacific Biosciences of California (NASDAQ:PACB), frequently referred to as PacBio, for $1.2 billion. The move paves the way for Illumina to get its foot in the door in the long-read sequencing market.
- [By Max Byerly]
Get a free copy of the Zacks research report on Pacific Biosciences of California (PACB)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Top 10 Value Stocks To Watch Right Now: Statoil ASA(STO)
Advisors’ Opinion:
- [By Matthew DiLallo]
Another highlight in April was that Shell gave the green light to the Vito project, which is a joint venture with Statoil (NYSE:STO) in the Gulf of Mexico. Shell and Statoil were able to cut that project’s cost estimate by 70% from the original design so that it’s now profitable at $35 a barrel. The partners expect the project to produce 100,000 BOE/D of low-cost oil and gas when it comes online in 2021.
- [By Tyler Crowe]
Anyone that has watched oil prices tick up recently has probably expected oil producers to report some impressive earnings results this past quarter, and Statoil (NYSE:STO) did just that with a 21% boost to the bottom line. At the same time, management is using all of its additional cash to do some wheeling and dealing that should help boost its growth possibilities in the nearer term.
- [By Shane Hupp]
Statoil (NYSE: STO) and Delek US (NYSE:DK) are both oils/energy companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, earnings, valuation, analyst recommendations, dividends, profitability and risk.